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The Sickle Cell Data Collection (SCDC) program collects health information about people with sickle cell 
disease (SCD) to study trends in diagnosis, treatment, and health care utilization in the United States. Georgia 
is one of two states currently participating in this Centers for Disease Control and Prevention initiative.
This brief is part of a series produced using data from SCDC Georgia that can inform decision-makers about 
critical gaps in diagnosis, treatment, and access to care for patients with SCD that might be filled through 
policy changes, improved health care practices, and education. This brief combines data on the number 
of new cases of SCD identified between 2004 and 2016 through the state’s newborn screening program 
and geographic information on where pediatric treatment centers are located. The results highlight how 
geography impacts access to specialized SCD care, which has implications for health care utilization, quality of 
care, and short- and long-term health outcomes for children.
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Georgia’s latest SCDC data shows that 
approximately 155 babies with SCD are born in the 
state each year, with rates staying relatively constant 
from year to year from 2004 through 2016. 
Babies with SCD are born in almost every county 
throughout Georgia (Figure 1). However, these 
births are not evenly distributed throughout the 
state. Five Metro Atlanta counties averaged more 
than 10 SCD births each year, while 100 counties in 
the state saw from one to 12 total SCD births over 
the entire 13-year period.
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Figure 1: SCD Births in Georgia 2004-2016 by County of 
Residence (n = 2,019*), with Locations of Specialty Care
New Cases of Sickle Cell Disease 
in Georgia
* Addresses are missing for 13 of these patients, so they are not 
represented on the map. 
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Connect with SCDC 
SCDC nationally: www.cdc.gov/ncbddd/hemoglobinopathies/scdc.html
SCDC Georgia: www.ghpc.gsu.edu/project/hemoglobin-disorders-data-coordinating-center
Contact Angela B. Snyder (angiesnyder@gsu.edu) if you would like to use SCDC Georgia data for your 
research or planning.
SCDC researchers categorized pediatric SCD care 
sites as either daily or periodic based on their 
staffing by pediatric sickle cell specialists, and used 
geographic information system software to map the 
one-hour drive radius around these facilities.
Currently, there are two comprehensive pediatric 
SCD centers in the state offering daily care (Children’s 
Healthcare of Atlanta with three sites and Augusta 
University with one). There are also pediatric SCD 
treatment centers with daily access in Macon (HOPE 
for Kids, Children’s Hospital, Navicent Health) and 
Savannah (Memorial Health). Additionally, there are 
six sites around the state that offer periodic sickle 
cell specialty clinics, typically one day per month at 
each site, alternating in-person and via telehealth. 
Children’s Medical Services, a program of the Georgia Department of Public Health, operates clinics in Albany, 
Dublin, Valdosta, and Waycross that are staffed by specialists from Augusta University. Augusta University hosts 
another in Athens, while Children’s Healthcare of Atlanta recently launched one in Columbus.
Of the babies born with SCD in Georgia from 2004 through 2016 —
• 76% live within a one-hour drive of a pediatric SCD treatment center with daily access
• 65% live within a one-hour drive of a comprehensive pediatric SCD center with daily access
• 14% live within a one-hour drive of a sickle cell specialty clinic with periodic access
• 10% live more than one hour from any pediatric specialty care for SCD
Access to Specialized Pediatric SCD Care
Conclusions
Figure 2: Number of Children with SCD Born in Georgia 
2004-2016 Who Live Within a One-hour Drive of a Daily or 
Periodic Pediatric SCD Specialty Care Clinic (n = 2,019*)
* Addresses are missing for 13 of these patients, so they are not included.
SCDC Georgia data shows that many children living with SCD and their families face the challenges of long 
drives and limited appointment availability to gain access to specialty care.
SCDC Georgia identified 3,509 individuals with SCD (ages 0 to 19 years) in Georgia in 2015. This translates to 
351 children who live more than one hour from any specialty care option and another 491 who live within an 
hour of a periodic specialty clinic only. It also suggests that Children’s Healthcare of Atlanta’s one-hour catch-
ment area is home to over 2,000 children with SCD.
These findings highlight locations in which specialty care access is absent or inadequate to meet the need. A 
number of efforts are underway to try to address these gaps: training for general practice clinicians, telehealth 
support for local providers under various models, and better education for patients and families. SCDC’s aim 
is for results like these to help inform strategies that will significantly improve the length and quality of life for 
individuals with SCD.
SCDC Georgia plans to further examine access issues. Research questions include these: How does access to 
specialty care affect short- and long-term health outcomes for individuals with SCD? How does access affect 
health care utilization and cost?
If you are a provider, patient advocate, or decision-maker with specific data analysis questions to improve your 
efforts on behalf of the SCD community, please contact us to discuss whether SCDC Georgia can help.
